Literature DB >> 24421790

A case of vertical transmission of Chagas disease contracted via blood transfusion in Canada.

Margaret A Fearon1, Vito Scalia1, Mary Huang1, Irene Dines1, Momar Ndao2, Philippe Lagacé-Wiens3.   

Abstract

Chagas disease is caused by the protozoan parasite Trypanosoma cruzi and is endemic in many countries in Latin America, where infected bugs of the Triatominea subfamily carry the parasite in the gut and transmit it to humans through fecal contamination of a bite. However, vertical transmission and transmission through blood transfusion and organ transplantation is well documented. Increasing immigration from endemic countries to North America has prompted blood operators, including Canadian Blood Services and Hema Quebec, to initiate blood donor testing for Chagas antibody. In the present report, an unusual case of vertical transmission from a mother, most likely infected through blood transfusion, and detected as part of a concurrent seroprevalence study in blood donors is described.

Entities:  

Keywords:  Chagas disease; Transfusion transmission; Vertical transmission

Year:  2013        PMID: 24421790      PMCID: PMC3630026          DOI: 10.1155/2013/406402

Source DB:  PubMed          Journal:  Can J Infect Dis Med Microbiol        ISSN: 1712-9532            Impact factor:   2.471


  14 in total

1.  Oral transmission of Chagas disease.

Authors:  Maria Aparecida Shikanai-Yasuda; Noemia Barbosa Carvalho
Journal:  Clin Infect Dis       Date:  2012-01-11       Impact factor: 9.079

2.  Control of Chagas disease. Report of a WHO Expert Committee.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  1991

3.  Transfusion-associated Trypanosoma cruzi infection in a non-endemic area.

Authors:  P Nickerson; P Orr; M L Schroeder; L Sekla; J B Johnston
Journal:  Ann Intern Med       Date:  1989-11-15       Impact factor: 25.391

4.  Congenital Chagas disease: estimating the potential risk in the United States.

Authors:  Zaida E Yadon; Gabriel A Schmunis
Journal:  Am J Trop Med Hyg       Date:  2009-12       Impact factor: 2.345

Review 5.  Chagas' disease and blood transfusion: a New World problem?

Authors:  S Wendel; A L Gonzaga
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

6.  Seroepidemiology of Trypanosoma cruzi, etiologic agent of Chagas' disease, in US blood donors.

Authors:  D A Leiby; E J Read; B A Lenes; A J Yund; R J Stumpf; L V Kirchhoff; R Y Dodd
Journal:  J Infect Dis       Date:  1997-10       Impact factor: 5.226

7.  Control of Chagas disease.

Authors: 
Journal:  World Health Organ Tech Rep Ser       Date:  2002

8.  Prevalence of antibody to Trypanosoma cruzi among blood donors in Los Angeles, California.

Authors:  P R Kerndt; H A Waskin; L V Kirchhoff; F Steurer; S H Waterman; J M Nelson; G A Gellert; I A Shulman
Journal:  Transfusion       Date:  1991 Nov-Dec       Impact factor: 3.157

9.  An estimate of the burden of Chagas disease in the United States.

Authors:  Caryn Bern; Susan P Montgomery
Journal:  Clin Infect Dis       Date:  2009-09-01       Impact factor: 9.079

10.  The sero-prevalence of antibodies to trypanosoma cruzi in Latin American refugees and immigrants to Canada.

Authors:  L S Steele; D W MacPherson; J Kim; J S Keystone; B D Gushulak
Journal:  J Immigr Minor Health       Date:  2007-01
View more
  7 in total

1.  Selective Testing of At-Risk Blood Donors for Trypanosoma cruzi and Plasmodium spp. in Switzerland.

Authors:  Christoph Niederhauser; Jochen Gottschalk; Caroline Tinguely
Journal:  Transfus Med Hemother       Date:  2016-05-03       Impact factor: 3.747

2.  Congenitally transmitted Chagas disease in Canada: a family cluster.

Authors:  Pierre J Plourde; Kamran Kadkhoda; Momar Ndao
Journal:  CMAJ       Date:  2017-12-04       Impact factor: 8.262

Review 3.  Worldwide Control and Management of Chagas Disease in a New Era of Globalization: a Close Look at Congenital Trypanosoma cruzi Infection.

Authors:  Carmen Muñoz; Montserrat Gállego; Alba Abras; Cristina Ballart; Anna Fernández-Arévalo; María-Jesús Pinazo; Joaquim Gascón
Journal:  Clin Microbiol Rev       Date:  2022-03-03       Impact factor: 50.129

4.  Benznidazole Extended-Release Tablets for Improved Treatment of Chagas Disease: Preclinical Pharmacokinetic Study.

Authors:  Marcelo Gomes Davanço; Michel Leandro Campos; Talita Atanazio Rosa; Elias Carvalho Padilha; Alejandro Henao Alzate; Larissa Araújo Rolim; Pedro José Rolim-Neto; Rosângela Gonçalves Peccinini
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

Review 5.  Preventing the transmission of American trypanosomiasis and its spread into non-endemic countries.

Authors:  Qin Liu; Xiao-Nong Zhou
Journal:  Infect Dis Poverty       Date:  2015-12-28       Impact factor: 4.520

6.  A family cluster of Chagas disease detected through selective screening of blood donors: A case report and brief review.

Authors:  Guillaume Mongeau-Martin; Momar Ndao; Michael Libman; Gilles Delage; Brian J Ward
Journal:  Can J Infect Dis Med Microbiol       Date:  2015 May-Jun       Impact factor: 2.471

7.  Towards Chagas disease elimination: Neonatal screening for congenital transmission in rural communities.

Authors:  Pamela Marie Pennington; José Guillermo Juárez; Margarita Rivera Arrivillaga; Sandra María De Urioste-Stone; Katherine Doktor; Joe P Bryan; Clara Yaseli Escobar; Celia Cordón-Rosales
Journal:  PLoS Negl Trop Dis       Date:  2017-09-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.